Tuo Zhang

656 total citations
23 papers, 446 citations indexed

About

Tuo Zhang is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Tuo Zhang has authored 23 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Nephrology, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Molecular Biology. Recurrent topics in Tuo Zhang's work include Acute Kidney Injury Research (7 papers), Chronic Kidney Disease and Diabetes (6 papers) and Renal and Vascular Pathologies (4 papers). Tuo Zhang is often cited by papers focused on Acute Kidney Injury Research (7 papers), Chronic Kidney Disease and Diabetes (6 papers) and Renal and Vascular Pathologies (4 papers). Tuo Zhang collaborates with scholars based in China, United States and Switzerland. Tuo Zhang's co-authors include Liuhua Hu, Ben He, Ben He, Linghong Shen, Shiqun Sun, Feng Yao, Xiaolei Wang, Beibei Sun, Zhe Sun and Ding Ding and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Cancer Research.

In The Last Decade

Tuo Zhang

20 papers receiving 439 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tuo Zhang China 12 170 139 85 76 71 23 446
Qiuju Wei China 12 159 0.9× 130 0.9× 45 0.5× 37 0.5× 76 1.1× 33 384
John F. Dimari United States 5 160 0.9× 135 1.0× 28 0.3× 24 0.3× 80 1.1× 8 411
Mária Godó Hungary 10 133 0.8× 237 1.7× 42 0.5× 130 1.7× 24 0.3× 18 478
Niki Prakoura France 13 121 0.7× 171 1.2× 76 0.9× 29 0.4× 62 0.9× 23 436
Jiejun Wen China 10 213 1.3× 176 1.3× 21 0.2× 36 0.5× 47 0.7× 14 463
Daphne H.T. IJpelaar Netherlands 8 246 1.4× 117 0.8× 41 0.5× 18 0.2× 59 0.8× 17 466
Longxing Cao China 8 64 0.4× 63 0.5× 142 1.7× 12 0.2× 201 2.8× 11 409
Yiwei Kong China 11 81 0.5× 180 1.3× 23 0.3× 102 1.3× 15 0.2× 13 343
Shenglei Zhang China 12 94 0.6× 161 1.2× 18 0.2× 56 0.7× 67 0.9× 43 348

Countries citing papers authored by Tuo Zhang

Since Specialization
Citations

This map shows the geographic impact of Tuo Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tuo Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tuo Zhang more than expected).

Fields of papers citing papers by Tuo Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tuo Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tuo Zhang. The network helps show where Tuo Zhang may publish in the future.

Co-authorship network of co-authors of Tuo Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Tuo Zhang. A scholar is included among the top collaborators of Tuo Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tuo Zhang. Tuo Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Tuo, et al.. (2026). Functionalized Wood: A Green Nanoengineering Platform for Sustainable Technologies. Nano-Micro Letters. 18(1). 108–108.
2.
Liu, Hanhan, Mingyang Sun, Yang Gao, et al.. (2025). Oral functional protein Z: Mitigation of thrombosis via thrombin inhibition to prevent cardiovascular disease. Colloids and Surfaces B Biointerfaces. 251. 114569–114569. 1 indexed citations
3.
Luo, Jinming, Shimao Fang, Tuo Zhang, et al.. (2025). Changes in alkaloids and their related metabolites during the processing of 'Qiancha 1′ white tea based on transcriptomic and metabolomic analysis. LWT. 218. 117435–117435. 3 indexed citations
4.
Zhang, Tuo, Jixian Zhang, Heng Zhang, et al.. (2025). Targeting granulosa cells with engineered DFO nanoparticles for the treatment of chemotherapy-induced premature ovarian failure. Theranostics. 15(15). 7820–7840.
5.
Dubey, Christelle, Tuo Zhang, Yanyun Gao, et al.. (2024). Chemotherapy increases CDA expression and sensitizes malignant pleural mesothelioma cells to capecitabine treatment. Scientific Reports. 14(1). 18206–18206. 1 indexed citations
6.
Liu, Yabing, Li Qin, Zhongying Liu, et al.. (2024). Solid-State Fermentation of Ganoderma lucidum on the Soluble Sugar Metabolism of Three Summer–Autumn Black Tea Varieties. Journal of Food Processing and Preservation. 2024. 1–18. 2 indexed citations
8.
Jing, Bo, Tong Wang, Beibei Sun, et al.. (2019). IL6/STAT3 Signaling Orchestrates Premetastatic Niche Formation and Immunosuppressive Traits in Lung. Cancer Research. 80(4). 784–797. 77 indexed citations
9.
Wang, Tong, Kaimi Li, Hongyong Song, et al.. (2019). p53 suppression is essential for oncogenic SPAG5 upregulation in lung adenocarcinoma. Biochemical and Biophysical Research Communications. 513(2). 319–325. 20 indexed citations
10.
Wang, Xiaolei, Tuo Zhang, Liuhua Hu, et al.. (2017). Comparison of Effects of Different Statins on Contrast‐Induced Acute Kidney Injury in Rats: Histopathological and Biochemical Findings. Oxidative Medicine and Cellular Longevity. 2017(1). 6282486–6282486. 22 indexed citations
11.
Zhang, Weifeng, Tuo Zhang, Ding Ding, et al.. (2017). Use of Both Serum Cystatin C and Creatinine as Diagnostic Criteria for Contrast‐Induced Acute Kidney Injury and Its Clinical Implications. Journal of the American Heart Association. 6(1). 18 indexed citations
12.
Zhang, Tuo, Shiqun Sun, Linghong Shen, & Ben He. (2016). GW27-e0026 Circulating microRNA-210 as an Early Biomarker for CI-AKI diagnosis. Journal of the American College of Cardiology. 68(16). C178–C178. 1 indexed citations
13.
Zhang, Tuo, Weifeng Zhang, Shiqun Sun, et al.. (2016). GW27-e0025 Combining Serum Cystatin C with Creatinine, a New Definition of Contrast-induced Acute Kidney Injury and Its Clinical Implications. Journal of the American College of Cardiology. 68(16). C174–C174.
14.
Sun, Shiqun, Tuo Zhang, Ding Ding, et al.. (2016). Circulating MicroRNA‐188, ‐30a, and ‐30e as Early Biomarkers for Contrast‐Induced Acute Kidney Injury. Journal of the American Heart Association. 5(8). 57 indexed citations
15.
Hu, Liuhua, Xiaolei Wang, Shiqun Sun, et al.. (2016). Xuezhikang ameliorates contrast media-induced nephropathy in rats via suppression of oxidative stress, inflammatory responses and apoptosis. Renal Failure. 38(10). 1717–1725. 13 indexed citations
16.
Sun, Shiqun, Tuo Zhang, Zhaohua Cai, et al.. (2015). Abstract 12855: Circulating miRNA-30a, -30e, -188 as Early Biomarkers for CI-AKI diagnosis. Circulation. 132(suppl_3). 2 indexed citations
17.
Zhao, Yichao, Tuo Zhang, Wen Zhou, et al.. (2014). Natriuretic Peptides as an Adjunctive Treatment for Acute Myocardial Infarction. International Heart Journal. 55(1). 8–16. 27 indexed citations
18.
He, Ben, et al.. (2013). Incidence and risk of developing contrast-induced acute kidney injury following intravascular contrast administration in elderly patients. Clinical Interventions in Aging. 9. 85–85. 34 indexed citations
19.
Zhao, Yichao, Tuo Zhang, Wen Zhou, et al.. (2013). Effect of Statin Pretreatment on Myocardial Perfusion in Patients Undergoing Primary Percutaneous Coronary Intervention: A Systematic Review and Meta‐analysis. Clinical Cardiology. 36(9). E17–24. 7 indexed citations
20.
Zhang, Tuo, et al.. (2011). Statins for the Prevention of Contrast-Induced Nephropathy: A Systematic Review and Meta-Analysis. American Journal of Nephrology. 33(4). 344–351. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026